BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9162201)

  • 1. Different cytogenetic patterns in skeletal breast cancer metastases.
    Adeyinka A; Pandis N; Nilsson J; Idvall I; Mertens F; Petersson C; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1996 May; 16(1):72-4. PubMed ID: 9162201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
    Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
    Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.
    Pandis N; Teixeira MR; Adeyinka A; Rizou H; Bardi G; Mertens F; Andersen JA; Bondeson L; Sfikas K; Qvist H; Apostolikas N; Mitelman F; Heim S
    Genes Chromosomes Cancer; 1998 Jun; 22(2):122-9. PubMed ID: 9598799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic findings in ductal carcinoma of the breast].
    Rojas-Atencio A; González L; Urdaneta K; Soto-Alvarez M; Prieto-Carrasquero M; Fulcado W; Quintero M; Boscán A; Alvarez Nava F
    Invest Clin; 1999 Sep; 40(3):179-89. PubMed ID: 10531751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells.
    Zhang R; Wiley J; Howard SP; Meisner LF; Gould MN
    Cancer Res; 1989 Jan; 49(2):444-9. PubMed ID: 2910462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
    Clar H; Langsenlehner U; Krippl P; Renner W; Leithner A; Gruber G; Hofmann G; Yazdani-Biuki B; Langsenlehner T; Windhager R
    Breast Cancer Res Treat; 2008 Oct; 111(3):449-52. PubMed ID: 17978878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
    Xu J; Chambers AF; Tuck AB; Rodenhiser DI
    Cancer Genet Cytogenet; 2008 Feb; 181(1):1-7. PubMed ID: 18262045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.
    Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schröck E; Dickson RB; Ried T
    Genes Chromosomes Cancer; 1999 Jul; 25(3):251-60. PubMed ID: 10379871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metastasis in breast carcinoma].
    Kölbl O; Kiricuta IC; Willner J; Flentje M
    Zentralbl Chir; 1997; 122(2):97-102. PubMed ID: 9173765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
    Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
    Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion.
    Leeming DJ; Delling G; Koizumi M; Henriksen K; Karsdal MA; Li B; Qvist P; Tankó LB; Byrjalsen I
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1392-5. PubMed ID: 16835341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.